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Abstract
Angioedema induced by the use of angiotensin converting
enzyme (ACE) inhibitors is an uncommon but life-threatening
complication, especially when the airway is affected, creating
unexpected difficult airway management.
A prompt differential diagnosis with anaphylactic shock is
critical, given that adrenaline treatment does not improve
angioedema.
We report a case of angioedema induced by ACE inhibitor
following in-hospital administration of captopril, with almost
impossible intubation, and secondary aspiration during airway
management. Angioedema was erroneously treated, because it
was mistakenly considered to be an anaphylactic reaction, and it
could have ended in death.
Resumen
El angioedema es una complicación poco frecuente relacionada
con el uso de inhibidores de la enzima convertidora de
angiotensina, pero potencialmente mortal, especialmente en el
caso de afectar a la vía aérea, generando vías aéreas difíciles no
previstas.
Es de vital importancia realizar un rápido diagnóstico difer-
encial del cuadro con el shock anafiláctico, dado que el
tratamiento con adrenalina, no mejora el angioedema.
Presentamos un caso de angioedema tras administración
intrahospitalaria de Captopril a un paciente sano, sin vía aérea
difícil prevista, generando una intubación casi imposible y
broncoaspiración secundaria durante el manejo de la vía aérea.
El cuadro clínico se desencadenó por la confusión del angioe-
dema, con una reacción anafiláctica, realizándose un tratamiento
inapropiado. Las consecuencias delmismopudieron sermortales.
Case description
This is the case of a 45-year-old male patient with no
known allergies, a history of untreated hypertension and
depression, and no relevant family history.
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The patient was admitted to the hospital for 3 days due
to renal failure and electrolyte and fluid imbalance
(metabolic alkalosis, hypokalemia, and symptomatic
hypomagnesemia) that were resolved. The condition
developed after 4 days of refusal to eat and drink during
the summer in an attempt at inflicting self-harm as a
result of a divorce process. At the time of the usual
verification of vital signs by the nursing staff on the day of
discharge, the patient was found to have high blood
pressure (BP) of 188/100 and was given captopril 25mg,
ordered by the attending physician.
Following the administration of the drug, the patient
began to report discomfort and showed evidence of lingual
pyrexia, oropharingeal itching, and swelling of the labial
mucosa. An allergic reaction was diagnosed based on the
clinical findings and the patient was given dexclorphenir-
amine 5-mg intravenous (IV) plus hydrocortisone 100-mg
IV. Six hours into the onset of the condition, the patient
reported difficulty swallowing and breathlessness, with
91% oxygen saturation, triggering activation of resuscita-
tion on the basis of a clinical diagnosis of anaphylactic
shock.
Upon arrival to the resuscitation service, the patientwas
found to have significant facial and cervical edema, a
sensation of dyspnea, 92% oxygen saturation (despite 50%
oxygen supplementation through face mask), sinus
tachycardia of 130bpm, and BP of 145/86. No pathological
signs were found on auscultation.
The patient was treated with intravenous corticoster-
oid, inhaled bronchodilator, and reservoir oxygen therapy
which improved the dyspnea sensation and oxygen
saturation to 95%. Given the vital signs (tachycardia and
hypertension), adrenaline was not administered and it
was decided to monitor and observe the patient.
After 4hours, the patient developed severe respiratory
distress with tachypnea and 83% oxygen saturation
despite oxygen therapy, increased cervical diameter and
lip swelling. The decision was made to proceed to
intubation and rapid sequence induction.
Following induction, the patient desaturated down to
50% O2 saturation on pulse oximetry. On direct laryngos-
copy, the patient was found to be Cormack III/IV,making it
impossible to intubate using the traditional laryngoscope
blade or the Frova introducer.
It was then considered to follow the Difficult Airway
Management Algorithm of the American Society of
Anaesthesiology 2013.1
Face mask ventilation was found to be very difficult,
with an inspiratory volume lower than required byweight.
Despite low-volume ventilation, the patient presented
vomiting, probably due to the pathophysiology of the
angioedema itself, and also perhaps because the patient
had been fasting formore than 8hours and ventilation had
been unsuccessful. Vomiting worsened saturation, to the
point that it was not sensed by the pulse oximeter.
Based on the description contained in the guidelines
and given the fact that the patient could not be intubated
or ventilated, a supraglottic device was considered but
then discarded due to the presence of vomiting, leading to
the consideration of the next step in the guidelines,
consisting of an emergency cricothyrotomy. However,
given neck anatomy, the resucitation staff was skeptical
about the outcome.
The team decided to change strategy and intubate with
a fiberoptic bronchoscope, considering that no other
option was feasible given the nature of the case, the
unavailability of otolaryngology specialists in the hospital,
and the fact that the attending physician was experienced
in the use of the device. Finally, intubation with the
fiberoptic bronchoscope was successful despite the fact
that airway visualizationwas not good, after 10minutes of
saturations below 90%.
The clinical team had not anticipated a difficult
intubation before the emergency because the patient
was stable on arrival to the resuscitation service, and no
consideration was given to a diagnosis of angioedema
induced by the use of angiotensin-converting enzyme
(ACE) inhibitors.
The patient remained intubated for 30hours until the
medical staff was certain that lip, lingual, and cervical
edema had resolved. The patient was diagnosed with ACE
inhibitor-induced angioedema and received treatment
with 2 bags of fresh frozen plasma, leading to full
remission of the facial and cervical edema. The patient
received prophylaxis with amoxicillin/clavulanic acid for
aspiration. Blood gases were within normal ranges from
the moment the patient was intubated, and the only
remarkable laboratory findings were leukocytosis of
17,000 and ACE activity of 11. The patient was extubated
without further incidents.
On discharge 6 days later, there were no clinical signs of
aspiration pneumonia, although radiological imaging
showed right lower pulmonary lobe condensation.
The patient reported that following captopril adminis-
tration, he noticed an itching sensation in the oropharynx
and difficulty breathing, but remembered nothing else
after anesthetic induction for intubation. Consent from
themedical institutionwas obtained for the publication of
this case for teaching purposes.
Discussion
Figures of 2001 estimated that 40 million people were
treated with ACE inhibitors in the world.2 Angioedema
was estimated to occur in 0.1% to 2.2% of all patients
treated with ACE inhibitors, although it appears that this
figure is an underestimation, considering that many cases
of angioedema are mistaken for allergic reactions to
medications, as was the case in the patient presented in
this paper.










It is crucial to identify the cases and to know how to
respond to angioedema associated with the use ACE
inhibitors because progression of this condition may be
fatal as time goes by. It is also of the greatest importance
not to think that drug effects on the airway are usually
allergic reactions because, in the case of an ACE inhibitor,
the condition is more often related to angioedema.3
Although the pathophysiology of angioedema is not
totally clear, ACE inhibitors are known to favor bradykinin
accumulation by inhibiting its breakdown. This kinin is a
powerful vasodilator, capable of inducing edema. Angioe-
dema has been attributed to this effect on bradykinin
metabolism. In the case of our patient, in whom a
reduction by almost 1/2 in the activity of the ACE was
documented, bradykinin accumulation could have been
even greater, leading to more severe clinical manifesta-
tions of vasodilation.4,5
The most common symptoms found in ACE inhibitor-
induced angioedema are swelling of the lips and tongue,
and dyspnea. ACE inhibitor-induced angioedema usually
affects head and neck, making airway management
difficult. For this reason, a difficult airway must always
be kept in mind in patients with respiratory distress
following the administration of an ACE inhibitor. Swelling
usually resolves within 24 to 48hours.
Angioedema is frequently associated with abdominal
symptoms such as pain, nausea, and vomiting. For this
reason, these patients must be considered high-risk when
it comes to orotracheal intubation because airway
swelling is compounded by a high probability of vomiting
during intubation.6
Clinical guidelines on the management of angioedema
have been recently published in the United States,7
addressed to emergency physicians, to avoid fatal cases,
usually due to difficult airway management. Those
guidelines underscore the need to give priority to airway
management in patients with facial swelling, especially
the lips, always using the algorithm for a difficult airway
and avoiding supraglottic devices. This point is especially
important because failure to recognize a difficult airway
due to angioedema, and its differences with an unexpect-
ed airway in terms of vomiting results in a tendency to use
guidelines which are not practical in this emergent
situation, usually based on the use of a supraglottic
device, which is actually contraindicated in these cases.
Conventional treatments such as H1 and H2 antago-
nists, oral corticosteroids, and adrenaline have been
shown not to be effective in angioedema progression,8
and should be avoided. In recent years, the use of fresh
frozen plasma for the treatment of this condition has been
growing, although its usefulness is not clear either.9 It is
worth noting that when a patient shows facial signs of
edema, the airway needs to be secured because there is a
high probability of progression, resulting in an unexpected
difficult airway as in the case we describe.
There is ongoing research using bradykinin receptor
antagonist icatibant, showing effectiveness of this agent
in cases of angioedema.10 However, large-scale clinical
trials are required.
Conclusion
Prompt diagnosis of ACE inhibitor-induced angioedema is
of vital importance to avoid fatal cases due to difficult
airway management. It is critical to remember that
angioedema is not a form of allergic reaction and,
consequently, is not treated the same way.
The use of ACE inhibitors needs to be included as part of
the signs of alert of urgent difficult airway considering the
wide use of thesemedications and their potential effect on
the airway. There is also a need to underscore the
importance of the presence of vomiting when it comes
to documenting a difficult airway and following the
current intubation guidelines.
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